Literature DB >> 3878758

In-vitro analysis of defective IgA production in selective IgA deficiency in childhood.

N Shinomiya, J Yata.   

Abstract

IgA production from B cells can be driven by three signals (anti-Ig antibody, B cell growth factor and helper T cell factor). It was thought that this three signal system might be a way other than the mitogen-stimulated system, to access B cell differentiation into Ig-producing cells. Seven children with IgA deficiency were investigated by this method. In all cases B cell differentiation was defective when using this three signal system. In one case, IgA producing cells were generated in normal number from B cells when stimulated with pokeweed mitogen in the presence of normal T cells. Definite abnormality of regulatory T cells in the IgA production was observed in only one case. These observations suggested that the main cause of IgA deficiency in most cases is the defect of B cells to differentiate into IgA secreting cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3878758      PMCID: PMC1577489     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  14 in total

1.  Defect in IgA secretion and in IgA specific suppressor cells in patients with selective IgA deficiency.

Authors:  T A Waldmann; S Broder; R Krakauer; M Durm; B Meade; C Goldman
Journal:  Trans Assoc Am Physicians       Date:  1976

2.  Quantitative measurements of T- and B-cell function in "variable" primary hypogammaglobulinaemia: evidence for a consistent B-cell defect.

Authors:  E G de la Concha; G Oldham; A D Webster; G L Asherson; T A Platts-Mills
Journal:  Clin Exp Immunol       Date:  1977-02       Impact factor: 4.330

3.  Functional assessment of a B cell defect in patients with selective IgA deficiency.

Authors:  J T Cassidy; G Oldham; T A Platts-Mills
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

Review 4.  The regulatory influence of activated T cells on B cell responses to antigen.

Authors:  D H Katz; B Benacerraf
Journal:  Adv Immunol       Date:  1972       Impact factor: 3.543

5.  Effect of irradiation and cyclophosphamide on anti-KLH antibody formation in mice.

Authors:  P E Hoffsten; F J Dixon
Journal:  J Immunol       Date:  1974-02       Impact factor: 5.422

6.  Human serum immunoglobulin concentrations: prevalence of immunoglobulin deficiencies.

Authors:  J T Cassidy; G L Nordby
Journal:  J Allergy Clin Immunol       Date:  1975-01       Impact factor: 10.793

7.  Anti-IgA in selective IgA deficiency. In vitro effects and Ig subclass pattern of human anti-IgA.

Authors:  L Hammarström; M A Persson; C I Smith
Journal:  Scand J Immunol       Date:  1983-12       Impact factor: 3.487

8.  Cellular aspects of selective IgA deficiency.

Authors:  G Delespesse; P Gausset; C Cauchie; A Govaerts
Journal:  Clin Exp Immunol       Date:  1976-05       Impact factor: 4.330

9.  Induction of proliferation and Ig production in human B leukemic cells by anti-immunoglobulins and T cell factors.

Authors:  K Yoshizaki; T Nakagawa; T Kaieda; A Muraguchi; Y Yamamura; T Kishimoto
Journal:  J Immunol       Date:  1982-03       Impact factor: 5.422

10.  Activation of human B lymphocytes. XII. Differential effects of in vitro cyclophosphamide on human lymphocyte subpopulations involved in B-cell activation.

Authors:  H C Stevenson; A S Fauci
Journal:  Immunology       Date:  1980-03       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.